PTGS2 and cancer: To investigate the importance of FASN and COX2 in cancer cell progression, these two enzymes were blocked with C75 (FASN inhibitor) and/or celecoxib (COX2 inhibitor) and the results showed a reduction in the amount of lipids formed per cell as well as decreased levels of cell survival proteins p-Erk and p-GSK3β [30].